Statin use may improve survival in patients with some blood cancers: Study Dr. Kamal Kant Kohli30 April 2025 9:00 AM ISTPatients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering statin medications at the...
Pirtobrutinib effective in patients of CLL pretreated with BTK inhibitors: NEJM Jacinthlyn Sylvia10 July 2023 9:00 AM ISTIn a recent clinical trial, pirtobrutinib, a highly selective noncovalent (reversible) Bruton's tyrosine kinase (BTK) inhibitor, has shown promising...
Alembic Pharma bags USFDA nod for mantle cell lymphoma drug Acalabrutinib Ruchika Sharma19 Jan 2023 3:15 PM ISTAcalabrutinib Capsules are indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy...
AstraZeneca Calquence gets Japenese nod for treatment-naïve chronic lymphocytic leukaemia Ruchika Sharma1 Jan 2023 10:00 AM ISTCalquence (acalabrutinib) is a next-generation, selective inhibitor of BTK.
AstraZeneca new tablet formulation of Calquence gets USFDA okay Ruchika Sharma8 Aug 2022 12:30 PM IST"The tablet can be taken with gastric acid-reducing agents, including proton pump inhibitors (PPIs), antacids and H2-receptor antagonists (H2RAs),"...
